Clinical trial Recruiting at 15 sites Observational Ages 18 and up

Understanding patient experiences after severe seizures

Official title: Patient-reported Outcomes in Status Epilepticus Requiring Intensive Care Unit Management. A Multicenter Longitudinal Cohort Study

Run by Versailles Hospital · NCT06100978 · Data updated 2026-11-12

This study looks at the long-term experiences and challenges faced by people who have survived severe seizures to see how it affects their daily lives and well-being.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment145 (estimated)
SponsorVersailles Hospital
Academic / other
Locations19 sites (Angoulême and 18 other locations)
StatusRecruiting
StartedMay 25, 2024
Main results expectedMarch 25, 2027
Study endsMarch 25, 2027
Registry record updatedJuly 7, 2026
Trial IDNCT06100978 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have survived status epilepticus and were discharged from the ICU between 3 months and 5 years prior.

Probably not a fit

Patients who are legal guardians, oppose participation, cannot communicate in French, or are not affiliated with a Social Security system may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the long-term outcomes and patient-reported experiences of individuals who have survived status epilepticus, a life-threatening neurological emergency. It focuses on assessing the functional impairments and quality of life in patients who required intensive care management. By analyzing data from patients who were previously part of the ICTAL registry, the study seeks to provide insights into the cognitive, physical, and mental challenges faced by these individuals post-ICU discharge. The findings could help improve care strategies for future patients.

Why it matters

Potential benefit: If successful, this study could enhance understanding of the long-term impacts of status epilepticus, leading to better patient care and support.

How similar studies have gone: While there has been limited research on the long-term outcomes of status epilepticus, this study addresses a relatively novel area of patient experience that has not been extensively explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults 18 years old or older
* Patients previously included in the ICTAL registry (Status Epilepticus cohort NCT03457831)
* Survivors after ICU management for Status Epilepticus More than 3 months and less than 5 years after ICU discharge

Exclusion Criteria:

* Legal guardianship
* Opposition to participate
* Unread and unwritten French language
* Patient not affiliated to a Social Security system

Where it's running

  • CH d'Angoulême
    Angoulême, France
    Recruiting
  • CH de Béthune
    Béthune, France
    Recruiting
  • CHU de Brest
    Brest, France
    Recruiting
  • CH de Cannes
    Cannes, France
    Recruiting
  • Hôpital Beaujon
    Clichy, France
    Recruiting
  • Hôpital Henri Mondor
    Créteil, France
    Recruiting
Show 13 more locations
  • CHU de Grenoble
    Grenoble, France
    Recruiting
  • CH de La Rochelle
    La Rochelle, France
    Recruiting
  • CH Versailles
    Le Chesnay, France
    Recruiting
  • CHU de Lyon
    Lyon, France
    Recruiting
  • CHU de Nantes
    Nantes, France
    Recruiting
  • Hôpital Paris Saint Joseph
    Paris, France
    Recruiting
  • CH de Roanne
    Roanne, France
    Recruiting
  • Hôpital Foch
    Suresnes, France
    Recruiting
  • CH de Toulon
    Toulon, France
    Recruiting
  • CH d'Arras
    Arras, France
    Not yet recruiting
  • CHU de Besançon
    Besançon, France
    Active not recruiting
  • CHU de Dijon
    Dijon, France
    Active not recruiting
  • CHU Tours
    Tours, France
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.